1. SY W, PL L. Chocolate: Food for Moods. Malays J Nutr 2011; 17(2).

2. Mackay J, Mensah GA, Greenlund K. The atlas of heart disease and stroke. World Health Organization; 2004.

3. Crozier A, Ashihara H, Tomás-Barbéran F, editors. Teas, cocoa and coffee: plant secondary metabolites and health. John Wiley & Sons; 2011 Oct 14.

4. Dillinger TL, Barriga P, Escárcega S, Jimenez M, Lowe DS, Grivetti LE. Food of the gods: cure for humanity? A cultural history of the medicinal and ritual use of chocolate. J Nutr 2000; 130(8): 2057S-72S.

5. Rapaille A, Gonze M, Van der Schueren F. Formulating sugar-free chocolate products with maltitol. Food Technol (Chicago) 1995; 49(7): 51-4.

6. Beck L. The health benefits of dark chocolate.

7. Kris-Etherton PM, Keen CL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Current Opinion Lipidol 2002; 13(1): 41-9.

8. Engler MB, Engler MM, Chen CY, Malloy MJ, Browne A, Chiu EY, et al. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Nutr 2004; 23(3): 197-204.

9. Jafarirad S, Ayoobi N, Karandish M, Jalali MT, Haghighizadeh MH, Jahanshahi A. Dark chocolate effect on serum adiponectin, biochemical and inflammatory parameters in diabetic patients: A randomized clinical trial. Int J Prev Med 2018; 9. [in Persian]

10. Hung HC, Joshipura KJ, Jiang R, Hu FB, Hunter D, Smith-Warner SA, et al. Fruit and vegetable intake and risk of major chronic disease. JNCI Cancer Institute 2004; 96(21): 1577-84.

11. Keen CL, Holt RR, Oteiza PI, Fraga CG, Schmitz HH. Cocoa antioxidants and cardiovascular health. Am J Clin Nutr 2005; 81(1): 298S-303S.

12. Grassi D, Lippi C, Necozione S, Desideri G, Ferri C. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons Am J Clin Nutr 2005; 81(3): 611-4.

13. Larsson SC, Virtamo J, Wolk A. Chocolate consumption and risk of stroke: a prospective cohort of men and meta-analysis. Neurology 2012; 79(12): 1223-9.

14. Grassi D, Desideri G, Ferri C. Protective effects of dark chocolate on endothelial function and diabetes. Curr Opin Clin Nutr Metab Care 2013; 16(6): 662-8.

15. Grassi D, Socci V, Tempesta D, Ferri C, De Gennaro L, Desideri G, et al. Flavanol-rich chocolate acutely improves arterial function and working memory performance counteracting the effects of sleep deprivation in healthy individuals. J Hypertens 2016; 34(7): 1298-308.

16. Larsson SC, Åkesson A, Gigante B, Wolk A. Chocolate consumption and risk of myocardial infarction: a prospective study and meta-analysis. Heart 2016; 102(13): 1017-22.

17. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999; 51(1): 83-133.

18. Fox M, Meyer-Gerspach AC, Wendebourg MJ, Gruber M, Heinrich H, Sauter M, et al. Effect of cocoa on the brain and gut in healthy subjects: A randomised controlled trial. Br J Nutr 2019; 121(6): 654-61.

19. De Vuyst L, Weckx S. The cocoa bean fermentation process: from ecosystem analysis to starter culture development. J Appl Microbiol 2016; 121(1): 5-17.

20. Afoakwa EO. Chocolate science and technology. John Wiley & Sons; 2016 Jun 13.

21. Aprotosoaie AC, Luca SV, Miron A. Flavor chemistry of cocoa and cocoa products—an overview. Compr Rev Food Sci Food Saf 2016; 15(1): 73-91.

22. Tomás-Barbéran F, Borges G, Crozier A. Phytochemicals in cocoa and flavan-3-ol bioavailability. Teas, cocoa and coffee: Plant secondary metabolites and health. 2011:193-217.

23. Tuenter E, Foubert K, Pieters L. Mood components in cocoa and chocolate: the mood pyramid. Planta Medica 2018; 84(12/13): 839-44.

24. Lorist MM, Tops M. Caffeine, fatigue, and cognition. Brain Cognition 2003; 53(1): 82-94.

25. Nehlig A. Is caffeine a cognitive enhancer?. J Alzheimer's Dis 2010; 20(s1): S85-94.

26. Smit HJ. Theobromine and the pharmacology of cocoa. Handb Exp Pharmacol 2011; (200): 201-34.

27. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. Sci World J 2013; 2013.

28. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radical Biol Med 2004; 36(7): 838-49.

29. Haslam E. Practical polyphenolics: from structure to molecular recognition and physiological action. Cambridge University Press; 1998 Mar 28.

30. Farzanmehr H, Abbasi SO, Sahari MA. Effects of sugar replacers on physicochemical, rheological and sensory properties of milk chocolate. Ir J Nutr Sci Food Technol 2008; 3(3): 65-82. [in Persian]

31. Beckett ST, Wells MA. Industrial Chocolate Manufacture and Use (2nd edn). Trends in Food Science and Technology. 1994; 5(11): 375-.

32. Takemorie T, Tsurumi T, Ito M, Kamiwaki T. Low calorie chocolate. US Patent. 1997(5,629,040).

33. Grassi D, Desideri G, Ferri C. Flavonoids: antioxidants against atherosclerosis. Nutrients 2010; 2(8): 889-902.

34. Grassi D, Desideri G, Croce G, Tiberti S, Aggio A, Ferri C. Flavonoids, vascular function and cardiovascular protection. Curr Pharm Des 2009; 15(10): 1072-84.

35. Wang JF, Schramm DD, Holt RR, Ensunsa JL, Fraga CG, Schmitz HH, et al. A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr 2000; 130(8): 2115S-9S.

36. Rein D, Lotito S, Holt RR, Keen CL, Schmitz HH, Fraga CG. Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status. J Nutr 2000; 130(8): 2109S-14S.

37. Zhang Z, Xu G, Liu X. Chocolate intake reduces risk of cardiovascular disease: evidence from 10 observational studies. Int J Cardiol 2013; 168(6): 5448-50.

38. Magrone T, Russo MA, Jirillo E. Cocoa and dark chocolate polyphenols: from biology to clinical applications. Frontiers in immunology. 2017:677.

39. Coe SD, Coe MD, Huxtable RJ. The true history of chocolate. Nature 1996; 382(6590): 411-.

40. León-Flores P, Nájera N, Pérez E, Pardo B, Jimenez F, Diaz-Chiguer D, et al. Effects of Cacao By-Products and a Modest Weight Loss Intervention on the Concentration of Serum Triglycerides in Overweight Subjects: Proof of Concept. J Med Food 2020; 23(7): 745-9.

41. Johnston K, Sharp P, Clifford M, Morgan L. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett 2005; 579(7): 1653-7.

42. Di Mattia CD, Sacchetti G, Mastrocola D, Serafini M. From cocoa to chocolate: The impact of processing on in vitro antioxidant activity and the effects of chocolate on antioxidant markers in vivo. Front Immunol 2017; 8: 1207.

43. Kongor JE, Hinneh M, Van de Walle D, Afoakwa EO, Boeckx P, Dewettinck K. Factors influencing quality variation in cocoa (Theobroma cacao) bean flavour profile—A review. Food Res Int 2016; 82: 44-52.

44. Fanton S, Cardozo LF, Combet E, Shiels PG, Stenvinkel P, Vieira IO, et al. The sweet side of dark chocolate for chronic kidney disease patients. Clin Nutr 2021; 40(1): 15-26.

45. Marx W, Kelly J, Marshall S, Nakos S, Campbell K, Itsiopoulos C. The effect of polyphenol-rich interventions on cardiovascular risk factors in haemodialysis: A systematic review and meta-analysis. Nutrients 2017; 9(12): 1345.

46. Güneş Bayir A, Aksoy A, KOÇYİĞİT A. The importance of polyphenols as functional food in health. Bezmialem Sci 2019; 7(2).

47. Gu Y, Hurst WJ, Stuart DA, Lambert JD. Inhibition of key digestive enzymes by cocoa extracts and procyanidins. J Agricultural Food Chem 2011; 59(10): 5305-11.

48. Sato M, Miyazaki T, Kambe F, Maeda K, Seo H. Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol 1997; 24(9): 1680-4.

49. Vlachopoulos C, Aznaouridis K, Alexopoulos N, Economou E, Andreadou I, Stefanadis C. Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens 2005; 18(6): 785-91.

50. Shiina Y, Funabashi N, Lee K, Murayama T, Nakamura K, Wakatsuki Y, et al. Acute effect of oral flavonoid-rich dark chocolate intake on coronary circulation, as compared with non-flavonoid white chocolate, by transthoracic Doppler echocardiography in healthy adults. Int J Cardiol 2009; 131(3): 424-9.

51. Wan Y, Vinson JA, Etherton TD, Proch J, Lazarus SA, Kris-Etherton PM. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr 2001; 74(5): 596-602.

52. Mursu J, Voutilainen S, Nurmi T, Rissanen TH, Virtanen JK, Kaikkonen J, et al. Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans. Free Radical Biol Med 2004; 37(9): 1351-9.

53. Allen RR, Carson L, Kwik-Uribe C, Evans EM, Erdman Jr JW. Daily consumption of a dark chocolate containing flavanols and added sterol esters affects cardiovascular risk factors in a normotensive population with elevated cholesterol. J Nutr 2008; 138(4): 725-31.

54. Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Meir S, Willett WC. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 1996; 313(7049): 84-90.

55. Counet C, Callemien D, Collin S. Chocolate and cocoa: New sources of trans-resveratrol and trans-piceid. Food Chem 2006; 98(4): 649-57.

56. Das S, Alagappan VK, Bagchi D, Sharma HS, Maulik N, Das DK. Coordinated induction of iNOS–VEGF–KDR–eNOS after resveratrol consumption: A potential mechanism for resveratrol preconditioning of the heart. Vascular Pharmacol 2005; 42(5-6): 281-9.

57. El-Mowafy AM, Alkhalaf M. Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis 2003; 24(5): 869-73.

58. De La Lastra CA, Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochemical Society Transactions 2007; 35(5): 1156-60.

59. Shang J, Chen LL, Xiao FX. Resveratrol improves high-fat induced nonalcoholic fatty liver in rats. Zhonghua gan zang bing za zhi= Zhonghua ganzangbing zazhi= Chin J Hepatol 2008; 16(8): 616-9.

60. Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 2011; 34(9): 2116-22.

61. Iso H, Date C, Wakai K, Fukui M, Tamakoshi A, JACC Study Group*. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Int Med 2006; 144(8): 554-62.

62. Wedick NM, Pan A, Cassidy A, Rimm EB, Sampson L, Rosner B, et al. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am J Clin Nutr 2012; 95(4): 925-33.

63. Van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged US women. Diabetes Care 2006; 29(2): 398-403.

64. Latif R. Health benefits of cocoa. Curr Opin Clin Nutr Metab Care 2013; 16(6): 669-74.

65. Hayek N. Chocolate, gut microbiota, and human health. Front Pharmacol 2013; 4: 11.

66. Tzounis X, Rodriguez-Mateos A, Vulevic J, Gibson GR, Kwik-Uribe C, et al. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr 2011; 93(1): 62-72.

67. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 2010; 104(S2): S1-63.

68. Duda-Chodak A. The inhibitory effect of polyphenols on human gut microbiota. J Physiol Pharmacol 2012; 63(5): 497-503.

69. Massot-Cladera M, Pérez-Berezo T, Franch A, Castell M, Pérez-Cano FJ. Cocoa modulatory effect on rat faecal microbiota and colonic crosstalk. Arch Biochem Biophysics 2012; 527(2): 105-12.

70. Strober LB. Fatigue in multiple sclerosis: a look at the role of poor sleep. Front Neurol 2015; 6: 21.

71. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol 1988; 45(4): 435-7.

72. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 2005; 128(5): 1016-25.

73. Wolkorte R, Heersema DJ, Zijdewind I. Muscle fatigability during a sustained index finger abduction and depression scores are associated with perceived fatigue in patients with relapsing-remitting multiple sclerosis. Neurorehabi Neural Repair 2015; 29(8): 796-802.

74. Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology 2013; 80(4): 409-16.

75. Sathyapalan T, Beckett S, Rigby AS, Mellor DD, Atkin SL. High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome. Nutr J 2010; 9(1): 1-5.

76. Sathyapalan T, Campion P, Beckett S, Rigby AS, Atkin SL. High cocoa polyphenol rich chocolate improves the symptoms of chronic fatigue. InEndocrine Abstracts 2006 Oct 1 (Vol. 12). Bioscientifica.

77. Coe S, Axelsson E, Murphy V, Santos M, Collett J, Clegg M,et al. Flavonoid rich dark cocoa may improve fatigue in people with multiple sclerosis, yet has no effect on glycaemic response: an exploratory trial. Clin Nutr ESPEN 2017; 21: 20-5.

78. Nehlig A. The neuroprotective effects of cocoa flavanol and its influence on cognitive performance. Br J Clin Pharmacol 2013; 75(3): 716-27.

79. Azevedo MI, Pereira AF, Nogueira RB, Rolim FE, Brito GA, Wong DV, et al. The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy. Molecular Pain 2013; 9: 1744-8069.

80. Yukawa GS, Mune M, Otani H, Tone Y, Liang XM, Iwahashi H, et al. Effects of coffee consumption on oxidative susceptibility of low-density lipoproteins and serum lipid levels in humans. Biochemistry (Moscow). 2004; 69(1): 70-4.

81. Garrett BE, Griffiths RR. The role of dopamine in the behavioral effects of caffeine in animals and humans. Pharmacology Biochemistry and Behavior. 1997; 57(3): 533-41.

82. Arendash, G.W. and C. Cao, Caffeine and coffee as therapeutics against Alzheimer's disease. J Alzheimer's Dis 2010; 20(s1): S117-S126.

83. Angelucci ME, Cesario C, Hiroi RH, Rosalen PL, Cunha CD. Effects of caffeine on learning and memory in rats tested in the Morris water maze. Braz J Med Biol Res 2002; 35: 1201-8.

84. Basurto-Islas G, Blanchard J, Tung YC, Fernandez JR, Voronkov M, Stock M, et al. Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease. Neurobiol Aging 2014; 35(12): 2701-12.

85. Cao C, Cirrito JR, Lin X, Wang L, Verges DK, Dickson A, et al. Caffeine suppresses amyloid-β levels in plasma and brain of Alzheimer's disease transgenic mice. J Alzheimer's Dis 2009; 17(3): 681-97.

86. Cunha, R.A. and P.M. Agostinho, Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J Alzheimer's Dis 2010; 20(s1): S95-S116.

87. Cooper KA, Donovan JL, Waterhouse AL, Williamson G. Cocoa and health: a decade of research. Br J Nutr 2008; 99(1): 1-1.

88. Faria A, Pestana D, Teixeira D, Couraud PO, Romero I, Weksler B, et al. Insights into the putative catechin and epicatechin transport across blood-brain barrier. Food Funct 2011; 2(1): 39-44.

89. Vauzour D, Vafeiadou K, Rodriguez-Mateos A, Rendeiro C, Spencer JP. The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr 2008; 3(3): 115-26.

90. Ghosh D, Scheepens A. Vascular action of polyphenols. Mol Nutr Food Res 2009; 53(3): 322-31.

91. Field DT, Williams CM, Butler LT, Consumption of cocoa flavanols results in an acute improvement in visual and cognitive functions. Physiol Behav 2011; 103(3-4): 255-60.

92. Fisher ND, Sorond FA, Hollenberg NK. Cocoa flavanols and brain perfusion. J Cardiovasc Pharmacol 2006; 47: S210-4.

93. Hollenberg NK, Fisher ND, McCullough ML. Flavanols, the Kuna, cocoa consumption, and nitric oxide. J Am Soc Hypertens 2009; 3(2): 105-112.

94. Fisher ND, Hughes M, Gerhard-Herman M, Hollenberg NK. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens 2003; 21(12): 2281-6.

95. Heiss C, Dejam A, Kleinbongard P, Schewe T, Sies H, Kelm M. Vascular effects of cocoa rich in flavan-3-ols. JAMA 2003; 290(8): 1030-1.

96. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, et al. Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc National Academy Sci 2006; 103(4): 1024-9.

97. Heiss C, Kleinbongard P, Dejam A, Perré S, Schroeter H, Sies H,et al. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Cardiol 2005; 46(7): 1276-83.

98. Scholey AB, French SJ, Morris PJ, Kennedy DO, Milne AL, Haskell CF. Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort. J Psychopharmacol 2010; 24(10): 1505-14.

99. Karabay A, Saija JD, Field DT, Akyürek EG. The acute effects of cocoa flavanols on temporal and spatial attention. Psychopharmacology 2018; 235(5): 1497-511.

100. Willner P, Benton D, Brown E, Cheeta S, Davies G, Morgan J, et al. “Depression” increases “craving” for sweet rewards in animal and human models of depression and craving. Psychopharmacology 1998; 136(3): 272-83.

101. Francis ST, Head K, Morris PG, Macdonald IA. The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol 2006; 47: S215-20.

102. Parker G, Roy K, Mitchell P, Wilhelm K, Malhi G, Hadzi-Pavlovic D. Atypical depression: a reappraisal. Am J Psychiat 2002; 159(9): 1470-9.

103. Harris M. Definition and classification of diabetes mellitus and the criteria for diagnosis. Leroith D, Olesky JM, Taylor SI. Diabetes mellitus: a fundamental and clinical text. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 457-61.

104. Bergenstal R. Management of type 2 diabetes: a systematic approach to meeting the standards of care II: oral agents, insulin, and managements of complications. Endocrinology 2001; 821-35.

105. Ramos S, Martín MA, Goya L. Effects of Cocoa Antioxidants in Type 2 Diabetes Mellitus. Antioxidants (Basel, Switzerland) 2017; 6(4): 84.

106. Bruno, G. and A. Landi. Epidemiology and costs of diabetes. in Transplantation proceedings. 2011. Elsevier.

107. Martin MÁ, Goya L, Ramos S. Antidiabetic actions of cocoa flavanols. Mol Nutr Food Res 2016; 60(8): 1756-69.

108. Shah SR, Alweis R, Najim NI, Dharani AM, Jangda MA, Shahid M,et al. Use of dark chocolate for diabetic patients: a review of the literature and current evidence. J Community Hosp Intern Med Perspect 2017; 7(4): 218-21.

109. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24(5): 816-23.

110. Grassi D, Desideri G, Mai F, Martella L, De Feo M, Soddu D, et al. Cocoa, glucose tolerance, and insulin signaling: cardiometabolic protection. J Agric Food Chem 2015; 63(45): 9919-26.

111. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44(2): S14-21.

112. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5): 1047-53.

113. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care 2008; 31(1): 96-8. [in Persian]

114. Abdoli S, Mardanian L. Mirzaei M. How public perceive diabetes: A qualitative study. Ir J Nurs Midwifery Res 2012; 17(5): 370. [in Persian]

115. Curtis PJ, Sampson M, Potter J, Dhatariya K, Kroon PA, Cassidy A. Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial. Diabetes Care 35(2): 226-32.

116. Jalil AM, Ismail A, Pei CP, Hamid M, Kamaruddin SH. Effects of cocoa extract on glucometabolism, oxidative stress, and antioxidant enzymes in obese-diabetic (Ob-db) rats. J Agricult Food Chem 2008; 56(17): 7877-84. [in Persian]

117. Davison G, Callister R, Williamson G, Cooper KA, Gleeson M. The effect of acute pre-exercise dark chocolate consumption on plasma antioxidant status, oxidative stress and immunoendocrine responses to prolonged exercise. Eur J Nutr 2012; 51(1): 69-79.

118. Dreosti IE. Antioxidant polyphenols in tea, cocoa, and wine. Nutrition (Burbank, Los Angeles County, Calif.) 2000;16(7-8): 692.

119. Selmi C, Cocchi CA, Lanfredini M, Keen CL, Gershwin ME. Chocolate at heart: The anti‐inflammatory impact of cocoa flavanols. Mol Nutr Food Res 2008; 52(11): 1340-8.

120. Oba S, Nagata C, Nakamura K, Fujii K, Kawachi T, Takatsuka N, et al. Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br J Nutr 2010; 103(3): 453-9.

121. Greenberg JA. Chocolate intake and diabetes risk. Clin Nutr 2015; 34(1): 129-33.

122. Tarka Jr SM, Morrissey RB, Apgar JL, Hostetler KA, Shively CA. Chronic toxicity/carcinogenicity studies of cocoa powder in rats. Food Chem Toxicol 1991; 29(1): 7-19.

123. Greenberg JA. Chocolate intake and diabetes risk. Clin Nutr 2015; 34(1):129-33.

124. Haghighat N, Rostami A, Eghtesadi S, Shidfar F, Heidari I, Hoseini AF. The effects of dark chocolate on lipid profile, apo-lipoprotein A-1, apo-lipoprotein B and inflammation in type-2 diabetic patients: a randomized clinical trial. Ir J Nutr Sci Food Technol 2013; 8(2): 21-30. [in Persian]

125. Taubert D, Berkels R, Roesen R, Klaus W. Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA 2003; 290(8): 1029-30.

126. Duffy SJ, Vita JA. Effects of phenolics on vascular endothelial function. Curr Opin Lipidol 2003; 14(1): 21-7.

127. Abdulrazzaq, N.A., The Risk Factors Associated With Metabolic Syndrome. Al-Mustansiriyah J Sci 2014; 25(3): 1-6.

128. Mackenzie GG, Carrasquedo F, Delfino JM, Keen CL, Fraga CG, Oteiza PI. Epicatechin, catechin, and dimeric procyanidins inhibit PMA‐induced NF‐κB activation at multiple steps in Jurkat T cells. FASEB J 2004; 18(1): 167-9.

129. Actis-Goretta L, Ottaviani JI, Keen CL, Fraga CG. Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett 2003; 555(3): 597-600.

130. Cai H, Griendling KK, Harrison DG. The vascular NAD (P) H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacological Sci 2003; 24(9): 471-8.

131. Flammer AJ, Frank Hermann, Isabella Sudano, Lukas Spieker, Matthias Hermann, Karen A Cooper, Mauro Serafini, Thomas F Lüscher, Frank Ruschitzka, Georg Noll, Roberto Cortiet .Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation, 2007. 116(21): 2376-82.

132. Esmaillzadeh, A. and L. Azadbakht, Dietary flavonoid intake and cardiovascular mortality. Br J Nutr 2008. 100(4): 695-7. [in Persian]

133. Stamler JS. S-nitrosothiols in the blood: roles, amounts, and methods of analysis. Circ Res 2004; 94(4): 414-7.

134. Foster MW, Pawloski JR, Singel DJ, Stamler JS. Role of circulating S-nitrosothiols in control of blood pressure. Hypertension 2005; 45(1):15-7.

135. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87(5): 1468-74.

136. Clark MG, Wallis MG, Barrett EJ, Vincent MA, Richards SM, Clerk LH, et al. Blood flow and muscle metabolism: a focus on insulin action. Am J Physiolo Endocrinol Metab 2003; 284(2): E241-58.

137. Grassi D, Necozione S, Lippi C, Croce G, Valeri L, Pasqualetti P, et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 2005; 46(2): 398-405.

138. Rostami A, Khalili M, Haghighat N, Eghtesadi S, Shidfar F, Heidari I, et al. High-cocoa polyphenol-rich chocolate improves blood pressure in patients with diabetes and hypertension. ARYA Atherosclerosis 2015; 11(1): 21. [in Persian]

139. Isogawa A, Noda M, Takahashi Y, Kadowaki T, Tsugane S. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2003; 361(9358): 703-4.

140. Greenberg JA, Axen KV, Schnoll R, Boozer CN. Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes 2005; 29(9): 1121-9.

141. Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ, et al. Coffee consumption and risk for type 2 diabetes mellitus. Annals of internal medicine. 2004 Jan 6; 140(1):1-8.

142. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New England J Med 1998; 339(4): 229-34.

143. Laville M, Nazare JA. Diabetes, insulin resistance and sugars. Obes Rev 2009; 10: 24-33.

144. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 2002; 76(1): 5-6.

145. Mellor DD, Sathyapalan T, Kilpatrick ES, Beckett S, Atkin SL. High‐cocoa polyphenol‐rich chocolate improves HDL cholesterol in Type 2 diabetes patients. Diabetic Med 2010; 27(11): 1318-21.

146. Magrone T, Russo MA, Jirillo E. Cocoa and dark chocolate polyphenols: from biology to clinical applications. Front Immunol 2017: 677.

147. Haghighat N, Rostami A, Eghtesadi S, Shidfar F, Heidari I, Hoseini A. The effects of dark chocolate on glycemic control and blood pressure in hypertensive diabetic patients: a randomized clinical trial. Razi J Med Sci 2013; 20(113): 78-86. [in Persian]

148. Guide to buying the best foreign and Iranian dark chocolates. (2021). Retrived from https://caferahnama.com/best-bitter-chocolate/